AbbVie (ABBV) said Wednesday the European Commission approved its Skyrizi drug for the treatment of adult patients with moderate to severe Crohn's disease,...
Teva Pharmaceutical Industries (TEVA) and Sandoz plan to boost the production of biosimilars to raise their share in that market, Reuters reported Tuesday,...
AbbVie (ABBV) said Monday the US Food and Drug Administration has accepted for priority review the company's biologics license application for epcoritamab,...
AbbVie (ABBV) has an average rating of outperform and price targets ranging from $120 to $200, according to analysts polled by Capital IQ. (MT Newswires...
AbbVie (ABBV) said Wednesday Health Canada has approved its Ubrelvy tablet for the acute treatment of migraine, with or without aura, in adults. Ubrelvy...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
AbbVie (ABBV) said Monday that the phase 2 study of AGN-151607, an investigational neurotoxin for the prevention of postoperative atrial fibrillation, a...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...